A synthetic peptide for use as a blocking control in assays to test for specificity of C2 orf25 antibody, Alternative Names: C2orf25 control peptide, C2orf25 antibody Blocking Peptide, Anti-C2orf25 Blocking Peptide, Methylmalonic Aciduria Blocking Peptide, Cobalamin Deficiency Cbld Type With Homocystinuria Blocking Peptide, CL25022 Blocking Peptide
Optimal conditions should be determined by the investigator
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Lyophilized
Rekonstitution
Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
Buffer
PBS
Handhabung
Avoid repeated freeze/thaw cycles.
Lagerung
-20 °C
Informationen zur Lagerung
Store at -20 °C long term.
Target
MMADHC
(Methylmalonic Aciduria (Cobalamin Deficiency) CblD Type, with Homocystinuria (MMADHC))
Hintergrund
Vitamin B12 (cobalamin) is an essential cofactor in several metabolic pathways. Intracellular conversion of cobalamin to adenosylcobalamin in mitochondria and to methylcobalamin in cytoplasm is necessary for homeostasis of methylmalonic acid and homocysteine. C2ORF25 encodes a protein involved in an early step of cobalamin metabolism.